CorMedix Inc. (CRMD) stock is up 45.66% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CRMD stock a score of 85 out of a possible 100.
That rank is influenced by a long-term technical score of 96. CRMD's rank also includes a fundamental score of 89. In addition to the average rating from Wall Street analysts, CRMD stock has a mean target price of 15.75. This means analysts expect the stock to gain 84.21% over the next 12 months. The short-term technical score for CRMD is 71.
What's Happening with CRMD Stock Today
CorMedix Inc. (CRMD) stock is up 7.82% while the S&P 500 is down -0.26% as of 11:10 AM on Wednesday, Nov 25. CRMD is up $0.62 from the previous closing price of $7.93 on volume of 315,455 shares. Over the past year the S&P 500 is up 15.46% while CRMD is up 45.66%. CRMD lost -$0.79 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on CorMedix Inc. (CRMD) Stock.
